Literature DB >> 9685945

Formulation and characterization of new layered diffusional matrices for zero-order sustained release.

N Chidambaram1, W Porter, K Flood, Y Qiu.   

Abstract

Statistical designs were used to study the effect of certain matrix formulation variables on the vitro release of a model compound, pseudoephedrine hydrochloride, from layered diffusional matrices designed for zero-order sustained release. These matrices consist of non-swellable, hydrophobic middle layers containing the active drug to which hydrophilic and/or hydrophobic barrier layers are press-coated. In general, linear release profiles can be obtained by applying hydrophilic barrier layers on both faces of a hydrophobic matrix tablet, or by applying a hydrophilic barrier layer on one face and a hydrophobic barrier layer on the other face of the matrix tablet. However, formulation and matrix variables in the barrier layers need to be controlled in order to achieve zero-order drug release from a hydrophobic matrix tablet coated with hydrophobic barrier layers on both faces.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685945     DOI: 10.1016/s0168-3659(97)00207-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

1.  Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.

Authors:  Ahmed A Aboelwafa; Emad B Basalious
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Formulation variables influencing drug release from layered matrix system comprising chitosan and xanthan gum.

Authors:  Thawatchai Phaechamud; Garnpimol C Ritthidej
Journal:  AAPS PharmSciTech       Date:  2008-07-25       Impact factor: 3.246

3.  Mechanical property characterization of bilayered tablets using nondestructive air-coupled acoustics.

Authors:  Ilgaz Akseli; Dipankar Dey; Cetin Cetinkaya
Journal:  AAPS PharmSciTech       Date:  2010-01-09       Impact factor: 3.246

4.  Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matrices.

Authors:  Tahseen Mirza; Srikant A Bykadi; Christopher D Ellison; Yongsheng Yang; Barbara M Davit; Mansoor A Khan
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

5.  Determination of diffusion coefficients of glycerol and glucose from starch based thermoplastic compounds on simulated physiological solution.

Authors:  M Alberta Araújo; Eugénio C Ferreira; António M Cunha; Manuel Mota
Journal:  J Mater Sci Mater Med       Date:  2005-03       Impact factor: 3.896

6.  Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on Carbopols with isosorbite mononitrate.

Authors:  M Efentakis; C Peponaki
Journal:  AAPS PharmSciTech       Date:  2008-08-07       Impact factor: 3.246

7.  Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen.

Authors:  Carla Martins Lopes; José M Sousa Lobo; João F Pinto; Paulo C Costa
Journal:  AAPS PharmSciTech       Date:  2007-09-21       Impact factor: 3.246

8.  Variables influencing drug release from layered matrix system comprising hydroxypropyl methylcellulose.

Authors:  Thawatchai Phaechamud
Journal:  AAPS PharmSciTech       Date:  2008-05-24       Impact factor: 3.246

Review 9.  Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery.

Authors:  Kovanya Moodley; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Valence M K Ndesendo; Pradeep Kumar; Shivaan Cooppan; Priya Bawa
Journal:  Int J Mol Sci       Date:  2011-12-22       Impact factor: 5.923

10.  Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy.

Authors:  Ortensia Ilaria Parisi; Mariarosa Ruffo; Rocco Malivindi; Anna Francesca Vattimo; Vincenzo Pezzi; Francesco Puoci
Journal:  Pharmaceutics       Date:  2020-01-03       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.